FDA Approves First-Ever Targeted MzL Treatment

FDA Approves First-Ever Targeted MzL Treatment

On January 19, 2017, the United States Food and Drug Administration (FDA) approved ibrutinib to treat patients that have received…

More...
World Health Organisation Revised Lymphoid Neoplasm Classifications

World Health Organisation Revised Lymphoid Neoplasm Classifications

The World Heath Organisation (WHO), has revised the classifications for lymphoid Neoplasms.  

More...
Phase 3 Study Promise With Obinutuzumab

Phase 3 Study Promise With Obinutuzumab

Results from a study show obinutuzumab-based immunochemotherapy and maintenance resulted in a significant improvement in progression-free survival compared with rituximab…

More...
Transplants with Cell Mutations Raise Risk of Secondary Cancers

Transplants with Cell Mutations Raise Risk of Secondary Cancers

According to a study, lymphoma patients receiving transplant treatment with their own blood stem cells may be at risk of…

More...

 

Global Database Search

 knowyoursubtype iconb   facebook2 twitter2 youtube1

IN THE NODE

Updates

 knowyoursubtype iconb   facebook2 twitter2 youtube1 Contact Us 

The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.